Dr. Wong is an Assistant Professor of Clinical Pharmacy at the University of Southern California (USC) School of Pharmacy and serves as a Faculty-in-Residence at Cedars-Sinai, providing clinical pharmacy services for the internal medicine teams and support for the experiential education program.
Dr. Wong received his Doctor of Pharmacy from the University of North Carolina Eshelman School of Pharmacy in 2013. He then completed a PGY1 Pharmacy Practice Residency at the University of Illinois at Chicago College of Pharmacy followed by a PGY2 Critical Care Pharmacy Residency at the University of Kentucky. Prior to joining USC, he worked as a Critical Care Pharmacist at Cedars-Sinai. He is board certified in critical care pharmacotherapy.
Areas of Expertise (4)
Critical Care Pharmacotherapy
University of North Carolina: Pharm.D. 2013
University of Maryland: B.S., Biological Sciences 2009
Selected Articles (3)
Wong PJ, Pandya KA, and Flannery AH
2017 Norepinephrine is the first-line vasopressor recommended for patients in septic shock. Weight-based dosing may increase drug exposure and the risk of adverse effects in obese patients. The objective was to evaluate the safety and efficacy of weight-based norepinephrine dosing using actual body weight in the morbidly obese compared with normal weight patients.
Wong PJ, Bailey AM, and Baum RA
2016 Warfarin is a vitamin K antagonist used to treat patients with hypercoagulable disease states but increases the risk of life-threatening bleeding. Prothrombin complex concentrate has been recommended if these bleeds occur. Kcentra, a 4-factor prothrombin complex concentrate, has been Food and Drug Administration approved for the urgent reversal of vitamin K antagonist–associated major bleeding. Hypotension has been reported with Kcentra use, but limited information is available about these reactions.
Wong P, Tesoro E, Aletich V, and Alaraj A
2015 The role of the VerifyNow test to guide clopidogrel therapy in neurosurgical patients is still unclear. This study compared outcomes in patients undergoing neurointerventional procedures on either standard clopidogrel or tailored clopidogrel regimens.